{
    "2021-10-27": [
        [
            {
                "time": "2021-10-27",
                "original_text": "复星医药前三季净利润同比增长43.8% 拟对外收购以丰富疫苗管线",
                "features": {
                    "keywords": [
                        "复星医药",
                        "净利润",
                        "同比增长",
                        "疫苗管线"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "复星医药前三季净利润36亿同比增44%，半年4次出售资产回收资金41亿",
                "features": {
                    "keywords": [
                        "复星医药",
                        "净利润",
                        "资产出售",
                        "资金回收"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "浙商证券维持复星医药买入评级，复星医药2021Q3业绩点评：符合预期，看好H2业绩表现",
                "features": {
                    "keywords": [
                        "浙商证券",
                        "买入评级",
                        "业绩点评",
                        "复星医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "中泰证券维持复星医药买入评级：创新多点开花，新冠疫苗带来可观增量",
                "features": {
                    "keywords": [
                        "中泰证券",
                        "买入评级",
                        "创新",
                        "新冠疫苗"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "国金证券维持复星医药买入评级：新品种放量持续，创新技术推进在望",
                "features": {
                    "keywords": [
                        "国金证券",
                        "买入评级",
                        "新品种",
                        "创新技术"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "复星医药：前三季实现净利润35.65亿元，同比增长43.8%",
                "features": {
                    "keywords": [
                        "复星医药",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "港股通】复星医药(02196)拟斥近40亿元收疫苗研发生产公司73.01%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "疫苗研发",
                        "股权收购"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-27",
                "original_text": "复星医药：以代价11.08亿收购目标公司32.52%的股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "股权收购",
                        "代价"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}